Grin logo
de en es fr
Shop
GRIN Website
Texte veröffentlichen, Rundum-Service genießen
Zur Shop-Startseite › Biologie - Krankheiten, Gesundheit, Ernährung

Plant Extracts against Pseudomonas Aeroginosa - in Vitro & in Vovo Studies

Titel: Plant Extracts against Pseudomonas Aeroginosa - in Vitro & in Vovo Studies

Wissenschaftliche Studie , 2011 , 95 Seiten , Note: None

Autor:in: Sriram Seshadri (Autor:in)

Biologie - Krankheiten, Gesundheit, Ernährung
Leseprobe & Details   Blick ins Buch
Zusammenfassung Leseprobe Details

Pseudomonas infections are very hard to treat in immunocompromised patients, in the post operational and other hospitalization related conditions and are responsible for high number of deaths. Thus Pseudomonas can be very notorious opportunistic pathogen. The major problem associated with chronic P. aeruginosa infections is the development of antibiotic resistance due to long continuous treatment durations in which the resistant mutants start to accumulate. Recent understandings regarding the development of antibiotic resistance have added a new dimension of hypermutator strains which have comparatively high rates of mutations then wild type strains. In Ayurveda, many plants and plant extracts have been widely used for treatment of diseases which may be due to bacterial, fungal or viral pathogen or due to imbalance in the body’s various systems. Modulation of immune response to alleviate disease has been one of the ways practiced in ayurveda including others such as re-establishing the imbalance in the body, lifestyle changes, and diet. The plants extracts used are seeds of Moringa oleifera, Nigella sativa, Vernonia anthelmintica, fruit of Terminalia chebula and root bark of Terminalia bellerica. These plant extracts have been shown to be effective as an antibacterial agent specifically against P. aeruginosa. The plant extracts used in this study are easily available and is being used in normal day-to-day life for various purpose and also have been proven to be effective medicine in Ayurveda.

Leseprobe


Table of Contents

Chapter 1: Introduction & Review of Literature

Characteristics

Pseudomonas aeruginosa as a Human pathogen

Virulence factors of P. aeruginosa

Quorum sensing: A Global Regulation System of P. aeruginosa Extracellular Virulence Factors

Host Defenses

Epidemiology and Control of P.aeruginosa Infections

Toxinogenesis

Current Therapeutic Approaches

Novel Therapeutic Approaches

Probable Drawbacks

Role of Plant Extracts

Chapter 2: Materials & Methods

Phase I In vivo study

Phase II In vitro study

Chapter 3: RESULTS

Chapter 4: DISCUSSION

Chapter 5: CONCLUSION

Chapter 6: REFERENCES

Objectives & Scope

This study aims to investigate the potential of antioxidants and host-modulating therapeutic agents derived from the ethanolic extracts of Acorus calamus and Semecarpus anacardium as an alternative or supportive treatment for chronic Pseudomonas aeruginosa lung infections in an animal model. The research focuses on the ability of these plant extracts to mitigate infection-related tissue damage and pathological outcomes.

  • Evaluating the anti-quorum sensing activity of selected Indian plant extracts against P. aeruginosa.
  • Analyzing the impact of plant extract mixtures on infection-induced virulence factors in vivo.
  • Assessing pathological changes and bacterial load in the lungs of rats post-infection and treatment.
  • Determining the efficacy of plant extracts in reducing oxidative stress and inflammatory damage in lung tissue.

Excerpt from the Book

Chapter 1: INTRODUCTION & REVIEW OF LITERATURE

P. aeruginosa is member of the Gamma Proteobacteria class of Bacteria. It is a Gram-negative, aerobic rod belonging to the bacterial family Pseudomonadaceae. P. aeruginosa is the type species of its group and it contains 12 other members (Kenneth, 2008). Like other members of the genus, P. aeruginosa is a free-living, gram negative rod shaped bacterium, commonly found in soil and water. It occurs regularly on the surfaces of plants and occasionally on the surfaces of animal body. They are one of the few groups of bacteria that are true pathogens of plants (Pitt, 1986; Robert and Dowling, 1998).

Pseudomonas can grow in many habitats including soil, surface waters, plants and various foods such as vegetables eaten by man (Neu, 1983; Robert and Dowling, 1998). P. aeruginosa has become increasingly recognized as an emerging opportunistic pathogen of clinical relevance. P. aeruginosa is a leading cause of nosocomial infections. The risk of emergence of antibiotic resistance may vary with different antibiotic treatments (Carmeli et al., 1997). As compared to hardcore bacterial pathogens, P. aeruginosa is only weakly pathogenic and in the host whose immune system is properly functioning, it is virtually non-virulent (Pitt, 1986). However Pseudomonas can cause severe form of infections which may be urinary tract, nosocomial or wound infections (Schaber et al., 2004). On the contrary, Pseudomonas infections are very hard to treat in immunocompromised patients, in the post operational and other hospitalization related conditions and are responsible for high number of deaths. Thus Pseudomonas can be very notorious opportunistic pathogen.

P. aeruginosa in nature is present as a saprophyte or pathogen of plants, insects and animal. In hospitals, P. aeruginosa can be found in sinks, respirators, humidifiers etc and is occasionally found on the hands of medical personnel (Neu, 1983; Pitt, 1986). P. aeruginosa is a leading cause of nosocomial infections, ranking second among the gram-negative pathogens reported to the National Nosocomial Infection Surveillance System (Harris et al., 2010).

Summary of Chapters

Chapter 1: Introduction & Review of Literature: Provides a comprehensive overview of P. aeruginosa as an opportunistic pathogen, its virulence mechanisms, quorum sensing systems, and current therapeutic challenges, alongside the medicinal potential of plant extracts.

Chapter 2: Materials & Methods: Details the experimental setup, including the rat infection model, the preparation of plant extracts, and the various microbiological and biochemical assays used to analyze infection progress and treatment effects.

Chapter 3: RESULTS: Presents the findings from the in vivo rat study and in vitro assays, demonstrating the impact of plant extracts on infection pathology, bacterial load, and virulence factor expression.

Chapter 4: DISCUSSION: Interprets the results by correlating the efficacy of plant extracts in managing infection-related tissue damage, inflammation, and virulence factors with broader clinical implications for treating chronic respiratory infections.

Chapter 5: CONCLUSION: Summarizes the study’s findings, affirming the potential of Acorus calamus and Semecarpus anacardium as supportive treatments and suggesting directions for future research into isolating bioactive compounds.

Chapter 6: REFERENCES: Lists all scientific sources and literature cited throughout the study.

Keywords

Pseudomonas aeruginosa, Quorum Sensing, Plant Extracts, Acorus calamus, Semecarpus anacardium, Chronic Lung Infection, Virulence Factors, Antibiotic Resistance, Biofilm, Oxidative Stress, Immunomodulation, Ayurveda, Pathogenesis, Inflammation, Bacteremia

Frequently Asked Questions

What is the primary focus of this research?

The research focuses on evaluating the therapeutic potential of plant extract mixtures, specifically from Acorus calamus and Semecarpus anacardium, in treating chronic P. aeruginosa lung infections.

What are the central themes of the work?

The central themes include the pathogenesis of P. aeruginosa, the role of quorum sensing in virulence, the problem of antibiotic resistance, and the application of traditional Ayurvedic knowledge for novel antimicrobial strategies.

What is the main objective of the study?

The primary objective is to test whether these plant extracts can act as immunomodulatory and antioxidative agents to reduce the severity of lung infections and tissue damage in an experimental rat model.

Which scientific methodology is employed?

The study uses an in vivo rat model of chronic lung infection alongside various in vitro assays to measure virulence factors such as LasA, LasB, pyocyanin, and biofilm formation.

What does the main body cover?

The main body covers the characteristics of the pathogen, details of experimental design, results regarding lung pathology and bacterial load, and a critical discussion of the results compared to existing scientific literature.

Which keywords define this work?

Key terms include P. aeruginosa, quorum sensing, plant extracts, chronic infection, biofilm, and oxidative stress.

How do plant extracts influence P. aeruginosa virulence in this study?

The extracts demonstrated a differential ability to reduce the production of virulence factors like elastase (LasA/LasB) and pyocyanin, thereby potentially dampening the pathogen's ability to cause tissue damage without relying solely on antibiotics.

What role does Quorum Sensing play in the pathogen's persistence?

Quorum sensing is identified as a critical global regulatory system that enables P. aeruginosa to coordinate the expression of virulence genes and biofilm formation, which are essential for surviving within the host environment.

Ende der Leseprobe aus 95 Seiten  - nach oben

Details

Titel
Plant Extracts against Pseudomonas Aeroginosa - in Vitro & in Vovo Studies
Veranstaltung
Department of Biochemistry & Biotechnology
Note
None
Autor
Sriram Seshadri (Autor:in)
Erscheinungsjahr
2011
Seiten
95
Katalognummer
V188467
ISBN (eBook)
9783656123804
ISBN (Buch)
9783656124344
Sprache
Englisch
Schlagworte
plant extracts pseudomonas aeroginosa vitro vovo studies
Produktsicherheit
GRIN Publishing GmbH
Arbeit zitieren
Sriram Seshadri (Autor:in), 2011, Plant Extracts against Pseudomonas Aeroginosa - in Vitro & in Vovo Studies, München, GRIN Verlag, https://www.grin.com/document/188467
Blick ins Buch
  • Wenn Sie diese Meldung sehen, konnt das Bild nicht geladen und dargestellt werden.
  • Wenn Sie diese Meldung sehen, konnt das Bild nicht geladen und dargestellt werden.
  • Wenn Sie diese Meldung sehen, konnt das Bild nicht geladen und dargestellt werden.
  • Wenn Sie diese Meldung sehen, konnt das Bild nicht geladen und dargestellt werden.
  • Wenn Sie diese Meldung sehen, konnt das Bild nicht geladen und dargestellt werden.
  • Wenn Sie diese Meldung sehen, konnt das Bild nicht geladen und dargestellt werden.
  • Wenn Sie diese Meldung sehen, konnt das Bild nicht geladen und dargestellt werden.
  • Wenn Sie diese Meldung sehen, konnt das Bild nicht geladen und dargestellt werden.
  • Wenn Sie diese Meldung sehen, konnt das Bild nicht geladen und dargestellt werden.
  • Wenn Sie diese Meldung sehen, konnt das Bild nicht geladen und dargestellt werden.
  • Wenn Sie diese Meldung sehen, konnt das Bild nicht geladen und dargestellt werden.
  • Wenn Sie diese Meldung sehen, konnt das Bild nicht geladen und dargestellt werden.
  • Wenn Sie diese Meldung sehen, konnt das Bild nicht geladen und dargestellt werden.
  • Wenn Sie diese Meldung sehen, konnt das Bild nicht geladen und dargestellt werden.
  • Wenn Sie diese Meldung sehen, konnt das Bild nicht geladen und dargestellt werden.
  • Wenn Sie diese Meldung sehen, konnt das Bild nicht geladen und dargestellt werden.
  • Wenn Sie diese Meldung sehen, konnt das Bild nicht geladen und dargestellt werden.
  • Wenn Sie diese Meldung sehen, konnt das Bild nicht geladen und dargestellt werden.
  • Wenn Sie diese Meldung sehen, konnt das Bild nicht geladen und dargestellt werden.
  • Wenn Sie diese Meldung sehen, konnt das Bild nicht geladen und dargestellt werden.
  • Wenn Sie diese Meldung sehen, konnt das Bild nicht geladen und dargestellt werden.
Leseprobe aus  95  Seiten
Grin logo
  • Grin.com
  • Versand
  • Kontakt
  • Datenschutz
  • AGB
  • Impressum